Liabilities and Equity of POINT Biopharma Global Inc. from 30 Jun 2020 to 30 Sep 2023

Taxonomy & unit: us-gaap: USD
Description: Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.
Summary: POINT Biopharma Global Inc. quarterly Liabilities and Equity in USD history and change rate from 30 Jun 2020 to 30 Sep 2023.
POINT Biopharma Global Inc. Liabilities and Equity for the quarter ending 30 Sep 2023 was $477,704,420, a 47% increase year-over-year.
Source SEC data: View on sec.gov

Liabilities and Equity, Quarterly (USD)

Liabilities and Equity, YoY Quarterly Change (%)

POINT Biopharma Global Inc. Quarterly Liabilities and Equity (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q3 2023	$477,704,420	+$152,016,574	+47%	30 Sep 2023	10-Q	13 Nov 2023	2023	Q3
Q2 2023	$497,774,772	+$263,530,150	+113%	30 Jun 2023	10-Q	14 Aug 2023	2023	Q2
Q1 2023	$558,524,209	+$305,541,952	+121%	31 Mar 2023	10-Q	15 May 2023	2023	Q1
Q4 2022	$578,322,736	+$315,064,094	+120%	31 Dec 2022	10-Q	13 Nov 2023	2023	Q3
Q3 2022	$325,687,846	+$48,491,930	+17%	30 Sep 2022	10-Q	14 Nov 2022	2022	Q3
Q2 2022	$234,244,622	-$63,218,007	-21%	30 Jun 2022	10-Q	12 Aug 2022	2022	Q2
Q1 2022	$252,982,257	+$116,484,165	+85%	31 Mar 2022	10-Q	13 May 2022	2022	Q1
Q4 2021	$263,258,642	+$241,064,147	+1086%	31 Dec 2021	10-K	27 Mar 2023	2022	FY
Q3 2021	$277,195,916	+$140,227,798	+102%	30 Sep 2021	10-Q	12 Nov 2021	2021	Q3
Q2 2021	$297,462,629	+$296,948,487		30 Jun 2021	10-Q	13 Aug 2021	2021	Q2
Q1 2021	$136,498,092			31 Mar 2021	10-Q	29 Apr 2021	2021	Q1
Q4 2020	$22,194,495			31 Dec 2020	10-K	25 Mar 2022	2021	FY
Q3 2020	$136,968,118			30 Sep 2020	10-Q	02 Nov 2020	2020	Q3
Q2 2020	$514,142^*			30 Jun 2020	10-Q	20 Aug 2020	2020	Q2

* An asterisk sign (*) next to the value indicates that the value is likely invalid.